The combination became known as fen-phen. American Home Products marketed Pondimin and Redux until September 1997. American Home: http://www.ahp.com l have to pay to resolve the diet drug lawsuits.</doc><doc The second drug in the combination, phentermine, was not linked to the problems. The two fen drugs sold by American Home Products were Pondimin and Redux, or dexfenfluramine. The second drug in the combination, phentermine, is still on the market. The Linnens and American Home Products settled the lawsuit after it went to trial. Jury selection began this week in a class-action lawsuit against American Home Products, which made fenfluramine. If too many people had opted out, American Home could have scrapped the settlement. An estimated 6.6 million people have used the diet drug combination. American Home Products pulled Pondimin and Redux off the market in 1997 at the Food and Drug Administration's request. American Home Products agreed in October to pay $3.75 billion to settle claims that the diet drugs had been harmful. Two versions were marketed _ fenfluramine, sold as Pondimin, and a purer version of the compound known as dexfenfluramine, or Redux. Those who did so retain the right to sue American Home for punitive damages. Madison, N.J.-based American Home Products is the nation's seventh-largest pharmaceutical company. American Home lost its bid to buy rival Warner-Lambert Co. in part because of uncertainty surrounding the diet drug litigation. Last month, another woman took American Home Products to court over heart-valve damage. About 500 of the fen-phen cases filed in
